GSK and Pfizer to Face 75,000 Zantac Lawsuits After Judge's Ruling
TL;DR Summary
GSK is preparing to face jury trials over its heartburn drug Zantac, which has been linked to legal issues.
- GSK set to face jury trials over heartburn drug Zantac Financial Times
- GSK, Pfizer Must Face 75000 Zantac Cases, Delaware Judge Rules Bloomberg
- Delaware Judge Lets More Than 70,000 Zantac Lawsuits Go Forward U.S. News & World Report
- GSK, Pfizer must face 75,000 Zantac cases, judge rules CNBCTV18
- Pfizer Settles 10,000 Zantac Lawsuits for Up to $250 Million DrugWatch.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
82%
107 → 19 words
Want the full story? Read the original article
Read on Financial Times